Nuvation Bio Inc. SEC filings NUVB

Nuvation Bio Inc. has 400 filings in SEC EDGAR's recent list, going back to May 15, 2020. Its latest annual report, Form ARS, was filed on Apr 10, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.

Nuvation Bio Inc. SEC filings
Form Description Filed Period
8-K Current report
Results of operations
Nov 4, 2026 Nov 4, 2026
10-Q Quarterly report Nov 4, 2026 Sep 30, 2026
4 Insider transaction Aug 21, 2026 Aug 19, 2026
144 Notice of proposed sale Aug 19, 2026 —
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
4 Insider transaction Jul 17, 2026 Jul 15, 2026
8-K Current report
New debt, Other events
Jul 6, 2026 Jun 30, 2026
8-K Current report
Material agreement, Agreement ended, New debt, Other events
Jun 30, 2026 Jun 24, 2026
424B5 Prospectus supplement Jun 29, 2026 —
305B2 Filing Jun 29, 2026 —
FWP Free writing prospectus Jun 26, 2026 —
424B5 Prospectus supplement Jun 25, 2026 —
4 Insider transaction Jun 24, 2026 Jun 23, 2026
4 Insider transaction Jun 24, 2026 Jun 23, 2026
4 Insider transaction Jun 24, 2026 Jun 23, 2026
144 Notice of proposed sale Jun 23, 2026 —
144 Notice of proposed sale Jun 23, 2026 —
144 Notice of proposed sale Jun 23, 2026 —
4 Insider transaction Jun 11, 2026 Jun 9, 2026
8-K Current report
Shareholder vote results
May 27, 2026 May 21, 2026
4 Insider transaction May 26, 2026 May 21, 2026
4 Insider transaction May 26, 2026 May 21, 2026
4 Insider transaction May 26, 2026 May 21, 2026
4 Insider transaction May 26, 2026 May 21, 2026
4 Insider transaction May 26, 2026 May 21, 2026
4 Insider transaction May 26, 2026 May 21, 2026
4/A Filing May 26, 2026 Feb 27, 2026
8-K Current report
Results of operations
May 4, 2026 May 4, 2026
10-Q Quarterly report May 4, 2026 Mar 31, 2026
4 Insider transaction Apr 21, 2026 Apr 17, 2026
4 Insider transaction Apr 21, 2026 Apr 17, 2026
DEFA14A Additional proxy material Apr 21, 2026 —
144 Notice of proposed sale Apr 17, 2026 —
144 Notice of proposed sale Apr 17, 2026 —
ARS Annual report to shareholders Apr 10, 2026 Dec 31, 2025
DEF 14A Proxy statement Apr 10, 2026 May 21, 2026
4 Insider transaction Apr 8, 2026 Apr 6, 2026
144 Notice of proposed sale Apr 6, 2026 —
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
S-8 Employee stock plan registration Mar 3, 2026 —
10-K Annual report Mar 2, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 2, 2026 Mar 2, 2026
25-NSE Delisting notice Feb 10, 2026 —
8-K Current report
Material agreement, Results of operations, Regulation FD disclosure
Jan 12, 2026 Jan 11, 2026
4 Insider transaction Dec 3, 2025 Dec 1, 2025
144 Notice of proposed sale Dec 1, 2025 —
4 Insider transaction Nov 26, 2025 Nov 25, 2025
144 Notice of proposed sale Nov 26, 2025 —
8-K Current report
Regulation FD disclosure, Other events
Nov 26, 2025 Nov 26, 2025
144 Notice of proposed sale Nov 25, 2025 —
4 Insider transaction Nov 24, 2025 Nov 20, 2025
4 Insider transaction Nov 24, 2025 Nov 20, 2025
4 Insider transaction Nov 21, 2025 Nov 19, 2025
144 Notice of proposed sale Nov 20, 2025 —
144 Notice of proposed sale Nov 20, 2025 —
4 Insider transaction Nov 19, 2025 Nov 17, 2025
144 Notice of proposed sale Nov 19, 2025 —
144 Notice of proposed sale Nov 19, 2025 —
8-K Current report
Regulation FD disclosure, Other events
Nov 17, 2025 Nov 17, 2025
144 Notice of proposed sale Nov 17, 2025 —
S-8 Employee stock plan registration Nov 3, 2025 —
10-Q Quarterly report Nov 3, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 3, 2025 Nov 3, 2025
4 Insider transaction Oct 29, 2025 Oct 27, 2025
144 Notice of proposed sale Oct 27, 2025 —
4 Insider transaction Aug 13, 2025 Aug 11, 2025
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 7, 2025 Aug 7, 2025
SCHEDULE 13G Ownership over 5% (passive) Jul 17, 2025 —
4 Insider transaction Jun 18, 2025 Jun 18, 2025
4 Insider transaction Jun 18, 2025 Jun 16, 2025
4 Insider transaction Jun 18, 2025 Jun 16, 2025
4 Insider transaction Jun 18, 2025 Jun 16, 2025
4 Insider transaction Jun 18, 2025 Jun 16, 2025
8-K Current report
Regulation FD disclosure, Other events
Jun 11, 2025 Jun 11, 2025
4 Insider transaction May 23, 2025 May 21, 2025
4 Insider transaction May 23, 2025 May 21, 2025
4 Insider transaction May 23, 2025 May 21, 2025
4 Insider transaction May 23, 2025 May 21, 2025
4 Insider transaction May 23, 2025 May 21, 2025
8-K Current report
Shareholder vote results
May 23, 2025 May 21, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 12, 2025 —
10-Q Quarterly report May 7, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 7, 2025 May 7, 2025
4 Insider transaction May 6, 2025 May 2, 2025
144 Notice of proposed sale May 2, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 28, 2025 —
4 Insider transaction Apr 8, 2025 Apr 4, 2025
ARS Annual report to shareholders Apr 8, 2025 Dec 31, 2024
DEF 14A Proxy statement Apr 8, 2025 May 21, 2025
4 Insider transaction Apr 3, 2025 Apr 1, 2025
8-K Current report
Material agreement
Mar 25, 2025 Mar 21, 2025
S-3ASR Automatic shelf registration Mar 6, 2025 —
10-K Annual report Mar 6, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 6, 2025 Mar 6, 2025
8-K Current report
Material agreement
Mar 5, 2025 Mar 3, 2025
4 Insider transaction Mar 4, 2025 Feb 28, 2025
4 Insider transaction Mar 4, 2025 Feb 28, 2025
4 Insider transaction Mar 4, 2025 Feb 28, 2025
4 Insider transaction Mar 4, 2025 Feb 28, 2025
4 Insider transaction Mar 4, 2025 Feb 28, 2025
4 Insider transaction Mar 4, 2025 Feb 28, 2025
4 Insider transaction Mar 4, 2025 Feb 28, 2025
4 Insider transaction Mar 4, 2025 Feb 28, 2025
4 Insider transaction Mar 4, 2025 Feb 28, 2025
8-K Current report
Material agreement, New debt
Mar 4, 2025 Mar 3, 2025
8-K Current report
Officer or director change
Feb 12, 2025 Feb 11, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 12, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Dec 6, 2024 —
4 Insider transaction Nov 13, 2024 Nov 11, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 12, 2024 —
8-K Current report
Results of operations
Nov 6, 2024 Nov 6, 2024
10-Q Quarterly report Nov 6, 2024 Sep 30, 2024
SC 13D/A Amended ownership over 5% (active) Oct 18, 2024 —
4 Insider transaction Oct 10, 2024 Oct 8, 2024
4 Insider transaction Oct 9, 2024 Oct 7, 2024
3 Initial insider ownership Oct 9, 2024 Oct 7, 2024
8-K Current report
Officer or director change
Oct 7, 2024 Oct 7, 2024
SC 13D Ownership over 5% (active) Sep 10, 2024 —
4 Insider transaction Sep 5, 2024 Sep 3, 2024
4 Insider transaction Sep 5, 2024 Sep 3, 2024
4 Insider transaction Sep 5, 2024 Sep 3, 2024
4 Insider transaction Sep 5, 2024 Sep 3, 2024
4 Insider transaction Sep 5, 2024 Sep 3, 2024
8-K Current report
Shareholder vote results, Other events
Sep 5, 2024 Sep 3, 2024
4 Insider transaction Sep 5, 2024 Sep 3, 2024
EFFECT Filing Aug 15, 2024 —
424B3 Prospectus Aug 15, 2024 —
DEFR14A Filing Aug 13, 2024 —
CORRESP Letter to the SEC Aug 12, 2024 —
UPLOAD Letter from the SEC Aug 8, 2024 —
S-3 Shelf registration Aug 5, 2024 —
10-Q Quarterly report Aug 5, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 5, 2024 Aug 5, 2024
ARS Annual report to shareholders Jul 30, 2024 Dec 31, 2023
DEF 14A Proxy statement Jul 30, 2024 Sep 3, 2024
UPLOAD Letter from the SEC Jul 16, 2024 —
CORRESP Letter to the SEC Jul 16, 2024 —
PRER14A Filing Jul 16, 2024 —
UPLOAD Letter from the SEC Jul 12, 2024 —
4 Insider transaction Jun 26, 2024 Jun 25, 2024
4 Insider transaction Jun 25, 2024 Jun 20, 2024
8-K/A Amended current report
Other events
Jun 20, 2024 Apr 9, 2024
CORRESP Letter to the SEC Jun 18, 2024 —
4 Insider transaction Jun 13, 2024 Jun 11, 2024
UPLOAD Letter from the SEC Jun 10, 2024 —
4 Insider transaction May 29, 2024 May 24, 2024
PRER14A Filing May 24, 2024 —
PRE 14A Preliminary proxy statement May 24, 2024 Jul 10, 2024
10-Q Quarterly report May 14, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 14, 2024 May 14, 2024
10-K/A Amended annual report Apr 26, 2024 Dec 31, 2023
S-8 Employee stock plan registration Apr 18, 2024 —
4 Insider transaction Apr 11, 2024 Apr 9, 2024
3 Initial insider ownership Apr 11, 2024 Apr 9, 2024
4 Insider transaction Apr 11, 2024 Apr 9, 2024
4 Insider transaction Apr 11, 2024 Apr 9, 2024
3 Initial insider ownership Apr 11, 2024 Apr 9, 2024
8-K Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Officer or director change, Bylaw or fiscal year change
Apr 10, 2024 Apr 9, 2024
3 Initial insider ownership Apr 2, 2024 Mar 27, 2024
SC 13D/A Amended ownership over 5% (active) Mar 26, 2024 —
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Mar 25, 2024 Mar 24, 2024
S-8 Employee stock plan registration Mar 4, 2024 —
4 Insider transaction Mar 4, 2024 Feb 29, 2024
4 Insider transaction Mar 4, 2024 Feb 29, 2024
4 Insider transaction Mar 4, 2024 Feb 29, 2024
4 Insider transaction Mar 4, 2024 Feb 29, 2024
4 Insider transaction Mar 4, 2024 Feb 29, 2024
4 Insider transaction Mar 4, 2024 Feb 29, 2024
4 Insider transaction Mar 4, 2024 Feb 29, 2024
10-K Annual report Feb 29, 2024 Dec 31, 2023
8-K Current report
Results of operations
Feb 29, 2024 Feb 29, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 9, 2024 —
SC 13G Ownership over 5% (passive) Jan 29, 2024 —
4 Insider transaction Jan 10, 2024 Jan 8, 2024
3 Initial insider ownership Jan 10, 2024 Jan 8, 2024
8-K Current report
Officer or director change
Jan 8, 2024 Jan 8, 2024
8-K Current report
Officer or director change
Dec 14, 2023 Dec 11, 2023
3 Initial insider ownership Nov 27, 2023 Nov 27, 2023
8-K Current report
Officer or director change
Nov 27, 2023 Nov 27, 2023
8-K Current report
Officer or director change
Nov 13, 2023 Nov 9, 2023
8-K Current report
Results of operations
Nov 2, 2023 Nov 2, 2023
10-Q Quarterly report Nov 2, 2023 Sep 30, 2023
4/A Filing Sep 22, 2023 Sep 19, 2023
4 Insider transaction Sep 21, 2023 Feb 19, 2023
10-Q Quarterly report Aug 3, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 3, 2023 Aug 3, 2023
4 Insider transaction May 17, 2023 May 15, 2023
4 Insider transaction May 17, 2023 May 15, 2023
4 Insider transaction May 17, 2023 May 15, 2023

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
NUVB (NYSE)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
New York, NY
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1811063
Former names
Panacea Acquisition Corp (until Feb 11, 2021)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.